Pooled analysis finds red and near-infrared light may modestly improve sleep quality, but evidence is thin
Researchers conducted a systematic review and meta-analysis of randomized controlled trials to assess whether photobiomodulation—the use of red or near-infrared light to stimulate tissue—affects self-reported sleep quality. Across five trials totaling 240 participants, pooled scores on a standard sleep-quality questionnaire improved compared with sham treatment, though the result was statistically marginal and the estimate imprecise.
- Source
- Lasers in medical science, 41(1), 2026
- Title
- Photobiomodulation and sleep quality: systematic review and meta-analysis.
- Authors
- Vital de Azevedo, de Souza, Defante, Salgado, Lopes-Martins, Gomes da Silva, et al.
- Design
- Systematic review and meta-analysis of RCTs · 5 trials · n = 240 · databases searched through September 2025
- Link
- doi.org/10.1007/s10103-026-04913-5 · PubMed 42322437
What the study found
The meta-analysis drew on five randomized controlled trials that compared photobiomodulation against sham (inactive) control conditions. The primary outcome was the Pittsburgh Sleep Quality Index, a widely used self-report measure where lower scores indicate better sleep. The pooled difference in scores favored the active treatment, but the confidence interval was wide—spanning from a clinically meaningful improvement to a near-zero effect—meaning the true benefit could be substantially smaller than the central estimate suggests.
Statistical heterogeneity across the included studies was moderate (I² ≈ 36%), indicating that the trials differed enough in design, population, or delivery approach that combining them introduces uncertainty. The authors note this methodological variation as a key limitation and caution that the finding should not be treated as definitive.
Alongside the clinical data, the review summarized mechanistic and neuroimaging research proposing that red and near-infrared light may influence mitochondrial activity, blood flow in the brain, and the behavior of support cells in neural tissue—pathways that could plausibly relate to sleep regulation. The authors present this as context rather than established explanation.
The authors explicitly describe the current body of evidence as limited and call for larger, standardized trials before conclusions about long-term effectiveness or safety can be drawn. The statistically significant pooled result (p = 0.03) sits at the threshold of conventional significance, reinforcing the need for replication.
Limits worth knowing
The review included only five trials with a combined 240 participants, a small evidence base that limits the reliability of any pooled estimate. The included populations spanned clinical and experimental groups, introducing variability in baseline sleep health, age, and underlying conditions that the authors acknowledge as methodological heterogeneity. Delivery parameters—wavelength, target area, session frequency, and duration—varied across studies and were not standardized, making it difficult to attribute effects to any particular approach. Long-term outcomes and safety data were not systematically captured. Funding sources for the individual trials are not detailed in the abstract, and it is unclear whether any industry support was present across the included studies.
What this means
This meta-analysis represents the most comprehensive pooling of randomized trial data on photobiomodulation and sleep quality published to date, but its five-trial, 240-person foundation means it moves the needle only modestly—establishing a signal worth investigating rather than a settled answer.
About this entry. The Heartwood Review summarizes published, peer-reviewed research in its own words and links to the original source. It is not medical advice; consult a physician before beginning or changing any thermal or recovery practice. Findings summarized here describe the study cited, not any product sold by Teak & Marble Atelier. Corrections.
Get new findings by email
New entries land most weeks. When they do, you’ll get a short note — findings only, no offers, no product news.